Literature DB >> 18758504

Restoration of endothelin-1-induced impairment in endothelium-dependent relaxation by interleukin-10 in murine aortic rings.

Saiprasad M Zemse1, Rob H P Hilgers, G Bryan Simkins, R Daniel Rudic, R Clinton Webb.   

Abstract

Endothelin-1 (ET-1) is implicated in the development of endothelial dysfunction through the generation of reactive oxygen species by NADPH oxidase activation. Interleukin-10 (IL-10) is an antiinflammatory cytokine that stimulates nitric oxide production, decreases superoxide production, and restores endothelial integrity after vascular injury. In this study, we tested whether IL-10 attenuates ET-1-induced endothelial dysfunction by improving acetylcholine (ACh)-induced relaxation of cultured murine aortic rings. Aortic rings (2 mm long) of C57BL/6 mice were incubated in 2 mL DMEM containing 120 U/mL penicillin and 120 microg/mL streptomycin in the presence of one of 4 treatments: vehicle (deionized water), ET-1 (100 nmol/L), recombinant mouse IL-10 (300 ng/mL), or a combination of both ET-1 and IL-10. After incubation at 37 degrees C for either 1 or 6 h (short-term exposure) or 22 h (overnight exposure), rings were mounted in a wire myograph and stretched to a passive force of 5 mN. Endothelium-dependent vasorelaxation was assessed by constructing cumulative concentration-response curves to ACh (0.001-10 micromol/L) during 10 mumol/L phenylephrine (PE)-induced contraction. Short-term exposure of ET-1 did not result in an impairment of ACh-induced relaxation. Overnight exposure of aortic rings to ET-1 resulted in a statistically significant endothelial dysfunction characterized by a reduced maximal relaxation response to ACh compared with that of untreated rings (Emax 57% +/- 3% versus 82% +/- 4%). IL-10 treatment restored ACh-induced relaxation (Emax 77% +/- 3%). Western blotting showed decreased eNOS expression in response to ET-1, whereas vessels treated with a combination of ET-1 and IL-10 showed increased expression of eNOS. Immunohistochemical analysis showed decreased eNOS expression in ET-1-treated vessels compared with those treated with both ET-1 and IL-10. We conclude that, in murine aorta, the antiinflammatory cytokine IL-10 prevents impairment in endothelium-dependent relaxation induced in response to long-term incubation with ET-1 via normalization of eNOS expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18758504      PMCID: PMC2759327          DOI: 10.1139/Y08-049

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  31 in total

1.  Endothelin-1 and endothelin-4 stimulate monocyte production of cytokines.

Authors:  M E Cunningham; M Huribal; R J Bala; M A McMillen
Journal:  Crit Care Med       Date:  1997-06       Impact factor: 7.598

2.  Cloning and expression of a cDNA encoding an endothelin receptor.

Authors:  H Arai; S Hori; I Aramori; H Ohkubo; S Nakanishi
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

3.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

4.  Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor.

Authors:  R J Gryglewski; R M Palmer; S Moncada
Journal:  Nature       Date:  1986 Apr 3-9       Impact factor: 49.962

5.  Plasma levels of immunoinhibitory cytokines interleukin-10 and transforming growth factor-beta in patients undergoing coronary artery bypass grafting.

Authors:  A Sablotzki; I Welters; N Lehmann; T Menges; G Görlach; M Dehne; G Hempelmann
Journal:  Eur J Cardiothorac Surg       Date:  1997-04       Impact factor: 4.191

6.  Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells.

Authors:  R M Touyz; E L Schiffrin
Journal:  Hypertension       Date:  1999-10       Impact factor: 10.190

7.  Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension.

Authors:  B Hocher; C Thöne-Reineke; P Rohmeiss; F Schmager; T Slowinski; V Burst; F Siegmund; T Quertermous; C Bauer; H H Neumayer; W D Schleuning; F Theuring
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

8.  Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

Authors:  A Giaid; M Yanagisawa; D Langleben; R P Michel; R Levy; H Shennib; S Kimura; T Masaki; W P Duguid; D J Stewart
Journal:  N Engl J Med       Date:  1993-06-17       Impact factor: 91.245

9.  Suppression of superoxide anion production by interleukin-10 is accompanied by a downregulation of the genes for subunit proteins of NADPH oxidase.

Authors:  S Kuga; T Otsuka; H Niiro; H Nunoi; Y Nemoto; T Nakano; T Ogo; T Umei; Y Niho
Journal:  Exp Hematol       Date:  1996-02       Impact factor: 3.084

10.  Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II.

Authors:  M J Pollman; T Yamada; M Horiuchi; G H Gibbons
Journal:  Circ Res       Date:  1996-10       Impact factor: 17.367

View more
  11 in total

1.  IL-10 supplementation increases Tregs and decreases hypertension in the RUPP rat model of preeclampsia.

Authors:  Ashlyn Harmon; Denise Cornelius; Lorena Amaral; Adrienne Paige; Florian Herse; Tarek Ibrahim; Gerd Wallukat; Jessica Faulkner; Janae Moseley; Ralf Dechend; Babbette LaMarca
Journal:  Hypertens Pregnancy       Date:  2015-05-21       Impact factor: 2.108

2.  Chronic social isolation in the prairie vole induces endothelial dysfunction: implications for depression and cardiovascular disease.

Authors:  Jacob D Peuler; Melissa-Ann L Scotti; Laura E Phelps; Neal McNeal; Angela J Grippo
Journal:  Physiol Behav       Date:  2012-03-26

3.  Interleukin-10 inhibits the in vivo and in vitro adverse effects of TNF-alpha on the endothelium of murine aorta.

Authors:  Saiprasad M Zemse; Chin Wei Chiao; Rob H P Hilgers; R Clinton Webb
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-07-16       Impact factor: 4.733

Review 4.  The role of inflammation in the pathology of preeclampsia.

Authors:  Ashlyn C Harmon; Denise C Cornelius; Lorena M Amaral; Jessica L Faulkner; Mark W Cunningham; Kedra Wallace; Babbette LaMarca
Journal:  Clin Sci (Lond)       Date:  2016-03       Impact factor: 6.124

Review 5.  The Role of Interleukin-10 in the Pathophysiology of Preeclampsia.

Authors:  Hajrunisa Cubro; Sonu Kashyap; Meryl C Nath; Allan W Ackerman; Vesna D Garovic
Journal:  Curr Hypertens Rep       Date:  2018-04-30       Impact factor: 5.369

Review 6.  Mechanisms and clinical implications of endothelium-dependent vasomotor dysfunction in coronary microvasculature.

Authors:  Sharif A Sabe; Jun Feng; Frank W Sellke; M Ruhul Abid
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-03-25       Impact factor: 5.125

7.  A novel endothelial-derived anti-inflammatory activity significantly inhibits spontaneous choroidal neovascularisation in a mouse model.

Authors:  Laura Paneghetti; Yin-Shan Eric Ng
Journal:  Vasc Cell       Date:  2016-05-11

8.  Mechanisms of vascular dysfunction in the interleukin-10-deficient murine model of preeclampsia indicate nitric oxide dysregulation.

Authors:  Hajrunisa Cubro; Karl A Nath; Sonja Suvakov; Oscar Garcia-Valencia; Santosh Parashuram; Wendy M White; Tracey L Weissgerber; Meryl C Nath; Natasa M Milic; Fernando Sontag; Livius V d'Uscio; Yi Zhu; James L Kirkland; Tamar Tchkonia; Mariam P Alexander; Reade A Quinton; Zvonimir S Katusic; Joseph P Grande; Vesna D Garovic
Journal:  Kidney Int       Date:  2020-11-02       Impact factor: 10.612

9.  Preeclampsia: From Inflammation to Immunoregulation.

Authors:  Denise C Cornelius
Journal:  Clin Med Insights Blood Disord       Date:  2018-01-10

10.  Interleukin-10 attenuates vascular responses to endothelin-1 via effects on ERK1/2-dependent pathway.

Authors:  Fernanda R C Giachini; Saiprasad M Zemse; Fernando S Carneiro; Victor V Lima; Zidonia N Carneiro; Glaucia E Callera; Adviye Ergul; R Clinton Webb; Rita C Tostes
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-12-12       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.